Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast
Rachael Natrajan(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Konstantin J. Dedes(University Hospital of Zurich), Christopher A. Maher(Washington University in St. Louis), Jessica Frankum(Institute of Cancer Research), Patty T. Wai(Institute of Cancer Research), Iwanka Kozarewa(AstraZeneca (United Kingdom)), Roger A’Hern, Britta Weigelt(Memorial Sloan Kettering Cancer Center), Ilirjana Bajrami(Institute of Cancer Research), Salvatore Piscuoglio(IRCCS Humanitas Research Hospital), Alicja Kopec(Institute of Cancer Research), Charlotte K.Y. Ng(Humanitas University), Alan Ashworth(University of California, San Francisco), Costas Mitsopoulos(Institute of Cancer Research), Caterina Marchiò(Candiolo Cancer Institute), David Hardisson(Universidad Autónoma de Madrid), Alan Mackay(Institute of Cancer Research), Christopher J. Lord(Institute of Cancer Research), Eleftherios Pierre Samartzis(University of Zurich), Anna Sapino(Candiolo Cancer Institute), Kerry Fenwick(Institute of Cancer Research), Chandan Kumar‐Sinha(Indira Gandhi Institute of Medical Sciences), Paul M Wilkerson(University Hospitals Bristol NHS Foundation Trust), Arul M. Chinnaiyan(University of Michigan), Maryou Lambros(Institute of Cancer Research), Jarle Hakas(Institute of Cancer Research)
Cited by 107
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k